GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human PIN1 complexed with covalent inhibitor

Analyse Crystal structure of human PIN1 complexed with covalent inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7EFX
Type
protein
Length
147 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptidyl-prolyl cis-trans isomerase nima-interacting 1
EC
5.2.1.8
UniProt
Q13526
Ligands
J3X
Pockets
1 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptidyl-prolyl cis-trans isomerase nima-interacting 1 (EC 5.2.1.8)protein14727% helix, 24% strandQ13526

Ligands and binding sites

  • J3X · 4-((5-bromofuran-2-yl)methyl)-8-(2-chloroacetyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1500.330.7811J3X

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7EFX · Crystal Structure of human PIN1 complexed with covalent inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.